BRIDGEWAY CAPITAL MANAGEMENT, LLC - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 145 filers reported holding ASSERTIO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$283,000
-48.1%
436,1000.0%0.01%
-14.3%
Q4 2019$545,000
-2.3%
436,1000.0%0.01%
-12.5%
Q3 2019$558,000
-29.5%
436,100
+90.1%
0.01%
-20.0%
Q2 2019$791,000
+36.4%
229,400
+100.5%
0.01%
+42.9%
Q1 2019$580,000114,4000.01%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 127,850$164,0000.08%
PERKINS CAPITAL MANAGEMENT INC 69,600$89,0000.08%
GLOBEFLEX CAPITAL L P 213,991$274,0000.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,500,000$1,920,000,0000.05%
DELTEC ASSET MANAGEMENT LLC 162,700$208,0000.05%
Spark Investment Management LLC 285,588$365,0000.05%
Factorial Partners, LLC 37,000$47,360,0000.04%
HighVista Strategies LLC 43,400$56,0000.04%
OAKTREE CAPITAL MANAGEMENT LP 1,492,455$1,910,0000.04%
OXFORD ASSET MANAGEMENT LLP 1,036,375$1,327,0000.03%
View complete list of ASSERTIO THERAPEUTICS INC shareholders